CTLA-4 polymorphisms are not associated with ocular inflammatory disease

Tissue Antigens

Volumn 72, Issue 1, 2008, Pages 49-53

  Bye, L ^a   Modi, N ^a   Stanford, M R ^a   Kondeatis, E ^a   Vaughan, R ^a   Fortune, F ^b   Kanawati, C ^c   Ben Chetrit, E ^d   Ghabra, M ^e   Murray, P I ^f   Wallace, G R ^f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c St John Eye Hospital   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e University Hospital   (Syrian Arab Republic)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Behcet's disease; Cytotoxic T lymphocyte associated antigen 4; Polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PRIMER DNA;

ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; CTLA 4 GENE; DNA EXTRACTION; DNA SEQUENCE; GENE; GENETIC ASSOCIATION; GENETIC RISK; HLA SYSTEM; HUMAN; INTERMEDIATE UVEITIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD; BEHCET SYNDROME; CASE-CONTROL STUDIES; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; UVEITIS, INTERMEDIATE;

EID: 45249099969     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01062.x     Document Type: Article

References (31)

1. Sharp A, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002 : 2 : 116 26.
2. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006 : 24 : 65 98.
3. Schneider H, Downey J, Smith A et al. Reversal of the stop signal by CTLA-4. Science 2006 : 313 : 1972 5.
4. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995 : 3 : 541 7.
5. Gough SC, Walker LS, Sansom DM. CTLA-4 gene polymorphism and autoimmunity. Immunol Rev 2005 : 204 : 102 15.
6. Kouki T, Sawai Y, Gardine CA et al. CTLA-4 gene polymorphism at position 49 of exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 2000 : 165 : 6606 11.
7. Donner H, Rau H, Walfish PG et al. CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease and type 1 diabetes mellitus. J Clin Endocrinol Metab 1997 : 82 : 143 6.
8. Ikegama H, Awata T, Kawasaki E et al. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J Clin Endocrinol Metab 91 : 1087 92.
9. Agarwal H, Jones DE, Daly AK et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000 : 32 : 538 41.
10. Tapirdamaz O, Pravica V, Metsaelaar HJ et al. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation. Gut 2006 : 55 : 863 8.
11. Bonfioli AA, Orefice F. Behcet's disease. Semin Ophthalmol 2004 : 20 : 199 206.
12. + T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease. Rheumatology 2004 : 43 : 843 51.
13. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behcet's disease: putative pathogenic role of interleukin-12. Arthritis Rheum 1999 : 42 : 1967 74.
14. Walton RC, Ashmore ED. Retinal vasculitis. Curr Opin Ophthalmol 2003 : 14 : 413 9.
15. International Study Group For Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990 : 335 : 1078.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988 : 16 : 1215.
17. Sallacki N, Bacanli A, Coskun M, Yavuzer U, Alpsoy E, Yegin O. CTLA-4 gene 49 A/G polymorphisms in Turkish patients with Behcet's disease. Clin Exp Dermatol 2005 : 30 : 546 50.
18. Gunescar R, Erken E, Bozkurt B, Ozer HT, Dinkei S, Erken EG. Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease. Int J Immunogenet 2007 : 34 : 45 9.
19. Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002 : 277 : 46478 86.
20. Karasneh J, Gul A, Ollier WE, Silman AJ, Worthington J. Whole-genome screening for susceptibility genes in multicase families with Behcet's disease. Arthritis Rheum 2005 : 52 : 1836 42.
21. Atan D, Turner SJ, Kilmartin DJ et al. Cytokine gene polymorphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci 2005 : 46 : 4245 50.
22. + regulatory T cells. Invest Ophthalmol Vis Sci 2006 : 47 : 5376 84.
23. Robinson MR, Chan CC, Yang JC et al. Cytotoxic T lymphocyte associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis. J Immunother 2004 : 27 : 478 9.
24. Maker AV, Phan GQ, Attia P et al. Tumour regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin-2: a phase I/II study. Ann Surg Oncol 2005 : 12 : 1005 16.
25. Kavvoura FK, Akamizu T, Awata T et al. CTLA-4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab 2007 : 92 : 3162 70.
26. Lee YH, Harley JB, Nath SK. CTLA-4 polymorphisms and systemic erythematosus (SLE): a meta-analysis. Hum Genet 2005 : 116 : 361 7.
27. Han S, Li Y, Mao Y, Xie Y. Meta-analysis of the association of CTLA-4 exon-1 + 49A/G polymorphism with rheumatoid arthritis. Hum Genet 2005 : 118 : 123 32.
28. Bagos PG, Karnaouri AC, Nikolopoulos GK, Hamodrakas SJ. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis. Mult Scler 2005 : 13 : 156 68.
29. McGonagle D, McDermott MF. A proposed classification of the immunological diseases PLoS Med 2006 : 3 : e297
30. Gul A. Behcet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005 : 4 : 81 3.
31. Chen Y, Vaughan RW, Kondeatis E et al. Are cytokine gene polymorphisms associated with outcome in patients with retinal vasculitis. Br J Ophthalmol 2005 : 89 : 1013 6.